Literature DB >> 8881450

Cytokine expression in human anterior pituitary adenomas.

V L Green1, S L Atkin, V Speirs, R V Jeffreys, A M Landolt, B Mathew, L Hipkin, M C White.   

Abstract

OBJECTIVE: There is increasing evidence for the role of cytokines in pituitary differentiated function and tumorigenesis, but the spectrum of cytokines found in the pituitary is unknown. Therefore profiles of cytokine expression were determined in different human anterior pituitary adenoma sub-types.
DESIGN: The reverse transcriptase-linked polymerase chain reaction (PCR) was used to identify the presence of cytokine mRNA within human pituitary adenomas. PATIENTS: Seventeen pituitary adenoma biopsies removed at transsphenoidal surgery were examined: 4 somatotrophinomas, 7 non-functional adenomas, 4 prolactinomas, one case of Cushing's disease and one case of Nelson's syndrome. MEASUREMENTS: RNA was extracted from each adenoma biopsy and reverse transcribed into cDNA. This was specifically amplified in a PCR using oligonucleotide primers complementary to each cytokine. The cytokines investigated were interleukin (IL)-I alpha, IL-I beta, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, tumour necrosis factor (TNF)-alpha, TNF-beta and transforming growth factor (TGF)-beta 1, beta 2 and beta 3. The products of each PCR were visualized using agarose gel electrophoresis.
RESULTS: All 17 adenomas expressed IL-8 transcripts, but no expression of IL-2, IL-5 or IL-7 was found. IL-6 was expressed in all 4 somatotrophinomas, 3 of 7 non-functional tumours, 2 of 4 prolactinomas and in the single case of Nelson's syndrome. At least one of the 3 isoforms of TGF-beta was found in all but 2 tumours; one prolactinoma and one non-functional adenoma. IL-1 alpha, IL-beta, IL-4, TNF-alpha and TNF-beta were expressed sporadically by individual adenomas.
CONCLUSION: These data suggest that whilst IL-8 may be important, the local expression of the cytokines IL-2, IL-5 and IL-7 is not important in human anterior pituitary tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8881450     DOI: 10.1046/j.1365-2265.1996.d01-1554.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  10 in total

1.  Analysis of differential gene expression by fiber-optic BeadArray and pathway in prolactinomas.

Authors:  Zhiquan Jiang; Songbo Gui; Yazhuo Zhang
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

2.  Growth promoting effect of human plasma ultrafiltrate bioactive fraction (TBP) for human non-functioning pituitary adenoma cells in vitro.

Authors:  N Zarković; M Hayn; F Tatzber; H Reichel; M Kor ić; K Zarković; V Plav ić; L J Breskovac; M Klingmüller; J Paladino
Journal:  J Endocrinol Invest       Date:  2000-12       Impact factor: 4.256

Review 3.  Molecular basis of pituitary oncogenesis.

Authors:  M Tada; H Kobayashi; T Moriuchi
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

4.  Combined high-field intraoperative magnetic resonance imaging and endoscopy increase extent of resection and progression-free survival for pituitary adenomas.

Authors:  Peter T Sylvester; John A Evans; Gregory J Zipfel; Richard A Chole; Ravindra Uppaluri; Bruce H Haughey; Anne E Getz; Julie Silverstein; Keith M Rich; Albert H Kim; Ralph G Dacey; Michael R Chicoine
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

5.  Estrogens modulate the inhibitory effect of tumor necrosis factor-alpha on anterior pituitary cell proliferation and prolactin release.

Authors:  S Theas; D Pisera; B Duvilanski; A De Laurentiis; M Pampillo; M Lasaga; A Seilicovich
Journal:  Endocrine       Date:  2000-06       Impact factor: 3.925

6.  TNF-α-induced VEGF and MMP-9 expression promotes hemorrhagic transformation in pituitary adenomas.

Authors:  Zhengzheng Xiao; Qin Liu; Feng Mao; Jun Wu; Ting Lei
Journal:  Int J Mol Sci       Date:  2011-06-23       Impact factor: 5.923

7.  Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours.

Authors:  V Speirs; S L Atkin
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

8.  Pathogenesis analysis of pituitary adenoma based on gene expression profiling.

Authors:  Weimin Wang; Zhiming Xu; Li Fu; Wei Liu; Xingang Li
Journal:  Oncol Lett       Date:  2014-10-13       Impact factor: 2.967

9.  Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours.

Authors:  Pedro Marques; Sayka Barry; Eivind Carlsen; David Collier; Amy Ronaldson; Sherine Awad; Neil Dorward; Joan Grieve; Nigel Mendoza; Samiul Muquit; Ashley B Grossman; Frances Balkwill; Márta Korbonits
Journal:  Acta Neuropathol Commun       Date:  2019-11-08       Impact factor: 7.801

Review 10.  Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System.

Authors:  Federica Barbieri; Stefano Thellung; Roberto Würth; Federico Gatto; Alessandro Corsaro; Valentina Villa; Mario Nizzari; Manuela Albertelli; Diego Ferone; Tullio Florio
Journal:  Int J Endocrinol       Date:  2014-11-17       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.